Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/2012
06/13/2012CN102488725A Brain-soothing emulsion for treating cardiovascular and cerebrovascular diseases and preparation method thereof
06/13/2012CN102488724A Brain-soothing dripping pills for treating cardiovascular and cerebrovascular diseases and preparation method thereof
06/13/2012CN102488723A Brain-soothing particles for treating cardiovascular and cerebrovascular diseases and preparation method thereof
06/13/2012CN102488722A Preparation method and quality detection method of bupleurum oral solution
06/13/2012CN102488720A Preparation method for submicron pine needle powder at normal temperature and special bidirectional air-flow screening machine
06/13/2012CN102488712A Artificial bezoar inclusion compound, its preparation method and application
06/13/2012CN102488698A Oral treatment water
06/13/2012CN102488688A Ophthalmic preparation by taking fibrauretinumrecisapierre as main drug
06/13/2012CN102488681A Ibuprofen diphenhydramine orally disintegrating tablet and preparation method thereof
06/13/2012CN102488680A Ibuprofen diphenhydramine dispersing tablet and preparation method thereof
06/13/2012CN102488678A Application of embelin to preparation of medicament for treating autoimmune disease
06/13/2012CN102488675A Applications of flavonoid compound used in preventing or curing of inflammatory diseases
06/13/2012CN102488672A Transdermal drug delivery system of hydrosol
06/13/2012CN102488662A Preparation methods of ibuprofen arginine powder injection for injection
06/13/2012CN102488651A Ibuprofen injection and its preparation method
06/13/2012CN102488614A Massage health-care ball
06/13/2012CN102145110B Oral medicine composition for clinically nursing high fever caused by infantile respiratory tract infection and preparation method of oral medicine composition
06/13/2012CN102058782B Traditional Chinese medicine powder for relieving pains in neck, shoulder, waist and leg
06/13/2012CN102038821B Method for preparing medicinal composition for treating dysmenorrhea
06/13/2012CN101897821B Granular preparation for promoting blood circulation, dredging collaterals and relieving pain and preparation method as well as detection method thereof
06/13/2012CN101843685B BC febrifugal refreshment paste for auxiliary treatment of fever and emergent physical hypothermia and preparation thereof
06/13/2012CN101837105B Chinese medicinal composition preparation, preparation method and quality detection method
06/13/2012CN101810844B External plaster for preventing disease and manufacturing method thereof
06/13/2012CN101766816B Dipolar molecule-modified mesoporous silicon material, preparation and application thereof
06/13/2012CN101757313B Liquid medicine
06/13/2012CN101703626B Medicament for treating rheumatoid arthritis
06/13/2012CN101670033B Ointment for curing protrusion of lumbar vertebral disc, sciatica, pain of neck, shoulder and legs, rheumatoid arthritis and hyperosteogeny
06/13/2012CN101648011B Tumor targeting recombinant DNA vaccine, preparation method thereof and application thereof
06/13/2012CN101636397B Urea compounds, preparation methods and pharmaceutical uses thereof
06/13/2012CN101612184B Multiradiate fleabane extract, composition containing same, preparation method and application thereof
06/13/2012CN101474260B Shuang Huanglian liquid preparation and method for measuring content thereof
06/13/2012CN101474258B Ficus microcarpa var.pusillifolia extract, extracting method and application of the extract
06/13/2012CN101472925B Purine derivatives for use as adenosin A2A receptor agonists
06/13/2012CN101333166B New depside compounds, preparation method thereof and use
06/13/2012CN101312977B Fused heterocyclic compounds useful as kinase modulators
06/13/2012CN101297667B Dandelion health-care tea and preparing process thereof
06/13/2012CN101198610B Process for preparing salts of 4-[[5-[(cyclopropylamino)carbonyl]-2-methylphenyl]amino]-5-methyl-n-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide and novel stable forms produced therein
06/12/2012US8198272 Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments
06/12/2012US8198234 Methods of suppressing microglial activation
06/12/2012US8197839 A miniature coated tablet or covered rod implant; smaller size and larger payloads than immediate release tablets; veterinary medicine
06/12/2012US8197813 Human antibodies that bind human TNFα
06/07/2012WO2012075381A1 Substituted purine and 7 - deazapurine compounds as modulators of epigenetic enzymes
06/07/2012WO2012075373A2 Solid dosage form that promotes reliable oral, esophageal and gi transit
06/07/2012WO2012075326A2 Treatment of inflammatory diseases by targeting the adaptor protein ciks
06/07/2012WO2012075244A2 Use of hemoglobin effectors to increase the bioavailability of therapeutic gases
06/07/2012WO2012075184A2 Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof
06/07/2012WO2012074926A1 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012WO2012074785A1 Pharmaceutical compositions comprising 3,4- dihydroisoquinolin-2(1 h)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity
06/07/2012WO2012074183A1 Pharmaceutical composition for preventing or treating inflammatory diseases comprising trachelospermi caulis extract and paeonia suffruticosa andrews extract, and method for preparing the same
06/07/2012WO2012074110A1 Orally disintegrating tablet
06/07/2012WO2012073856A1 Oil-in-water emulsion composition containing difluprednate and tobramycin
06/07/2012WO2012073184A1 Quinolin-4 (1h) -one derivatives as inhibitors of phosphatidylinositol 3-kinases
06/07/2012WO2012072791A2 2-(1-phenyl-4,5,6,7-tetrahydro-1h-indazol-4-yl)ethylamine derivatives useful as sigma receptor inhibitors
06/07/2012WO2012072782A1 Use of sigma ligands in bone cancer pain
06/07/2012WO2012072727A1 Crystalline modification of n-(3,5-dichloropyridin-4-yl)-[1-(4 -fluorobenzyl)-7-azaindol-3-yl)]glyoxylic acid amide as inhibitor of pde4
06/07/2012WO2012027274A3 Compositions and methods for imaging
06/07/2012WO2012019178A9 Methods of treating and diagnosing acute chest syndrome
06/07/2012WO2011159071A3 Peptide having antimicrobial or anti-inflammatory activity and pharmaceutical composition containing same as an active ingredient
06/07/2012WO2011023986A8 Kinase inhibitors
06/07/2012US20120142779 Stable injectable compositions
06/07/2012US20120142778 Microbiological method for synthesizing cinnamoyl amide derivatives of amino acids
06/07/2012US20120142777 Pharmaceutical composition comprising gabapentin or an analogue thereof and an alpha-aminoamide and its analgesic use
06/07/2012US20120142773 Use of pufas for treating skin inflammation
06/07/2012US20120142772 Benzo Lipoxin Analogues
06/07/2012US20120142766 Substituted 1,3-dioxanes and their uses
06/07/2012US20120142759 Soluble thf receptors and their use in treatment of disease
06/07/2012US20120142758 Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
06/07/2012US20120142755 Compositions for preventing, reducing or treating keratinocyte-mediated inflammation
06/07/2012US20120142751 Methods for the production of biliverdin
06/07/2012US20120142748 Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
06/07/2012US20120142747 Compositions and methods for delivering clonidine to a target tissue site
06/07/2012US20120142745 Novel phenyl oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142744 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
06/07/2012US20120142743 Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate
06/07/2012US20120142740 Novel alkene derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142739 Novel oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142736 Novel pyridine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142735 Disubstituted [4-(5-aminomethyl-phenyl)-piperidin-1-yl]- 1h-indol-3-yl]-methanones
06/07/2012US20120142733 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of ccr2
06/07/2012US20120142732 Heteroaryls and uses thereof
06/07/2012US20120142729 KAT ll INHIBITORS
06/07/2012US20120142726 Pharmaceutical compositions comprising 3,4-dihydroisoquinolin-2(1h)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity
06/07/2012US20120142716 4-pyrimidinesulfamide derivative
06/07/2012US20120142713 Crystalline forms of 6-(1h-imidazol-1-yl)-2-phenylquinazoline
06/07/2012US20120142711 Acid-labile trigger units
06/07/2012US20120142709 Substituted pyridinone-pyridinyl compounds
06/07/2012US20120142708 Substituted pyridine urea compounds
06/07/2012US20120142704 Pharmaceutical solution of cetirizine hydrochloride
06/07/2012US20120142696 Substituted indole/indazole-pyrimidinyl compounds
06/07/2012US20120142692 Antifolate combinations
06/07/2012US20120142691 Picolinamide derivatives as ttx-s blockers
06/07/2012US20120142689 Serotonin reuptake inhibitors
06/07/2012US20120142681 Heterocyclic hydrazone compounds
06/07/2012US20120142678 Novel compound useful for the treatment of degenerative and inflammatory diseases
06/07/2012US20120142677 Pyrrolidine Compounds Which Modulate The CB2 Receptor
06/07/2012US20120142671 Benzamides and nicotinamides as syk modulators
06/07/2012US20120142670 N-(amino-heteroaryl)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy
06/07/2012US20120142669 N-(amino-heteroaryl)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy
06/07/2012US20120142667 Pyrimidine derivatives as zap-70 inhibitors
06/07/2012US20120142666 Azetidine 2-Carboxamide Derivatives Which Modulate The CB2 Receptor
1 ... 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 ... 1272